
    
      The primary objectives of this study are:

        1. To evaluate the safety of [64Cu]FBP8 and its whole body distribution, metabolism,
           pharmacokinetics, and radiation burden in healthy volunteers.

        2. To establish the accuracy of [64Cu]FBP8 -PET to detect left atrial thrombosis in
           patients with atrial fibrillation.
    
  